Table 3 Prescribed medicines for COPD patients
GOLD II | GOLD III | GOLD IV | Total | |
|---|---|---|---|---|
(n = 12) | (n = 21) | (n = 10) | (n = 43) | |
Short acting bronchodilator | 75.0% | 80.9% | 80.0% | 79.1% |
Combined LABA with steroid | 58.3% | 61.9% | 70.0% | 62.8% |
Antibiotics | 58.3% | 61.9% | 60.0% | 60.5% |
Expectorants | 50% | 52.4% | 70.0% | 55.8% |
Combined ≥2 bronchodilators | 50.% | 76.2% | 70.0% | 67.4% |
Long acting bronchodilator | 16.7% | 9.5% | 20.0% | 14.0% |
Anti-tussive | 8.3% | 47.6% | 10.0% | 27.9% |
Chinese traditional medicine | 8.3% | 19.1% | 20.0% | 16.3% |
Oral corticosteroids | 0.0% | 14.3% | 0.0% | 7.0% |
ICS | 0.0% | 0% | 10.0% | 2.3% |